T1	chemical 0 19	receptor antagonist
T2	chemical 21 29	bosentan
T3	disease_or_phenotypic_feature 112 118	facial
T4	disease_or_phenotypic_feature 119 125	cancer
T5	disease_or_phenotypic_feature 126 130	pain
T6	disease_or_phenotypic_feature 160 171	hypokalemia
T7	disease_or_phenotypic_feature 176 181	edema
T8	chemical 243 253	antagonist
T9	chemical 263 273	eplerenone
T10	chemical 353 361	solution
T11	disease_or_phenotypic_feature 366 387	cardiac insufficiency
T12	disease_or_phenotypic_feature 389 402	renal failure
T13	chemical 404 409	water
T14	chemical 472 478	oxygen
T15	disease_or_phenotypic_feature 493 504	oral cancer
T16	disease_or_phenotypic_feature 634 655	psychiatric disorders
T17	disease_or_phenotypic_feature 664 670	autism
T18	chemical 675 679	drug
T19	chemical 754 766	radiolabeled
T20	chemical 843 851	antigens
T21	disease_or_phenotypic_feature 879 885	glioma
T22	disease_or_phenotypic_feature 898 905	obesity
T23	chemical 914 922	estrogen
T24	chemical 932 944	Daunorubicin
T25	chemical 1024 1028	drug
T26	disease_or_phenotypic_feature 1037 1045	leukemia
T27	chemical 1073 1079	oxygen
T28	disease_or_phenotypic_feature 1134 1147	heart failure
T29	chemical 1189 1198	adenylate
T30	chemical 1260 1267	hormone
T31	chemical 1379 1386	hormone
T32	disease_or_phenotypic_feature 1387 1396	dependent
T33	chemical 1415 1426	amphetamine
T34	disease_or_phenotypic_feature 1457 1464	sarcoma
T35	chemical 1506 1512	oxygen
T36	disease_or_phenotypic_feature 1574 1580	autism
T37	chemical 1591 1598	glucose
T38	chemical 1600 1604	urea
T39	chemical 1605 1613	nitrogen
T40	chemical 1633 1644	amylase - a
T41	disease_or_phenotypic_feature 1664 1672	cataract
T42	chemical 1674 1692	alpha-Chymotrypsin
T43	disease_or_phenotypic_feature 1709 1717	cataract
T44	chemical 1727 1736	enzymatic
T45	disease_or_phenotypic_feature 1759 1765	mutant
T46	chemical 1774 1785	bevacizumab
T47	chemical 1803 1813	biological
T48	chemical 1823 1832	Serotonin
T49	chemical 1842 1852	inhibitors
T50	chemical 1889 1894	label
T51	disease_or_phenotypic_feature 1913 1919	autism
T52	chemical 1921 1932	Bupivacaine
T53	disease_or_phenotypic_feature 1967 1982	pulmonary edema
T54	disease_or_phenotypic_feature 2023 2052	cancer-associated retinopathy
T55	chemical 2063 2071	antigens
T56	chemical 2123 2131	antigens
T57	disease_or_phenotypic_feature 2291 2297	cancer
T58	chemical 2338 2341	DCs
T59	disease_or_phenotypic_feature 2371 2387	hyperinsulinemia
T60	chemical 2389 2396	glucose
T61	disease_or_phenotypic_feature 2410 2417	obesity
T62	missed_disease_or_phenotypic_feature 39 65	tumor-induced ongoing pain
T63	missed_disease_or_phenotypic_feature 70 93	evoked hypersensitivity
R1	treats Arg1:T2 Arg2:T62	
R2	treats Arg1:T2 Arg2:T63	
T64	corrected_disease_or_phenotypic_feature 112 131	facial cancer pain.
R3	treats Arg1:T2 Arg2:T64	
T65	missed_disease_or_phenotypic_feature 146 158	hypertension
T66	corrected_chemical 215 253	selective mineralocorticoid antagonist
T67	corrected_chemical 278 302	low-dose corticosteroids
R4	treats Arg1:T66 Arg2:T7	
R5	treats Arg1:T66 Arg2:T6	
R6	treats Arg1:T66 Arg2:T65	
R7	treats Arg1:T9 Arg2:T7	
R8	treats Arg1:T9 Arg2:T6	
R9	treats Arg1:T9 Arg2:T65	
R10	treats Arg1:T67 Arg2:T7	
R11	treats Arg1:T67 Arg2:T6	
R12	treats Arg1:T67 Arg2:T65	
T68	corrected_chemical 341 361	fleet enema solution
R13	causes_or_contributes_to Arg1:T68 Arg2:T11	
R14	causes_or_contributes_to Arg1:T68 Arg2:T12	
T69	missed_disease_or_phenotypic_feature 404 431	water-electrolyte imbalance
T70	missed_disease_or_phenotypic_feature 437 442	ileus
R15	causes_or_contributes_to Arg1:T68 Arg2:T69	
R16	treats Arg1:T68 Arg2:T70	
T71	corrected_disease_or_phenotypic_feature 1032 1052	CDF1 leukemia tumors
T72	missed_chemical 946 961	nanoerythrosome
T73	corrected_chemical 932 972	Daunorubicin--nanoerythrosome conjugates
R17	treats Arg1:T73 Arg2:T71	
R18	treats Arg1:T24 Arg2:T71	
T74	missed_disease_or_phenotypic_feature 1325 1330	tumor
R19	causes_or_contributes_to Arg1:T30 Arg2:T74	
T75	corrected_chemical 1495 1512	Hyperbaric oxygen
R20	treats Arg1:T75 Arg2:T36	
T76	corrected_disease_or_phenotypic_feature 1754 1772	KRAS mutant tumors
R21	treats Arg1:T46 Arg2:T76	
T77	corrected_chemical 1823 1852	Serotonin reuptake inhibitors
T78	missed_chemical 1854 1859	SSRIs
R22	treats Arg1:T78 Arg2:T51	
R23	treats Arg1:T77 Arg2:T51	
T79	missed_disease_or_phenotypic_feature 1941 1962	myocardial depression
R24	causes_or_contributes_to Arg1:T52 Arg2:T79	
R25	causes_or_contributes_to Arg1:T52 Arg2:T53	
